RecallDepth
Class II Terminated

Clozapine Tablets USP, 25 mg, 100-count bottle (NDC 0093-4359-01), 500- count bottle (NDC 0093-4359-05), 100 Unit Dose Blisters per carton (NDC 0093-4359-93), Individual Blister Pack (NDC 0093-4359-19), Rx Only, Manufactured By: Teva Pharmaceutical Industries Ltd., Jerusalem, 9777600, Israel

This recall has been terminated (originally issued May 17, 2017).

Company
Teva Pharmaceuticals Usa
Recall Initiated
April 24, 2017
Posted
May 17, 2017
Recall Number
D-0705-2017
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
North Wales, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Microbial Contamination of Non-Sterile Products

Distribution

Nationwide

Lot / Code Info

100 (NDC 0093-4359-01) and 500 count bottles (NDC 0093-4359-05)- Lot # 07C160; Exp. 03/18 100 Unit Dose Blisters/Carton (NDC 0093-4359-93) and Individual Blister Pack (NDC 0093-4359-19) - Lot # 07C160A; Exp. 03/18

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls